CV Sciences (CVSI) Research & Development (2013 - 2026)

CV Sciences' (CVSI) quarterly Research & Development came in at $18000.0 in Q1 2026, down 40.0% year-on-year from $30000.0 in Q1 2025, and little changed quarter-over-quarter from $18000.0 in Q4 2025.

CV Sciences (CVSI) Research & Development (2013 - 2026) Analysis & Trends

CV Sciences has disclosed Research & Development across 14 years of filings, most recently posting $18000.0 for Q1 2026.

  • Research & Development for Q1 2026 came in at $18000.0, down 40.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $110000.0 (up 17.02% YoY), and the FY2025 annual result was $122000.0, up 22.0% from the prior year.
  • Research & Development came in at $18000.0 for Q1 2026 at CV Sciences, roughly flat from $18000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $121000.0 in Q1 2022 to a low of $7000.0 in Q4 2024.
  • The 5-year median for Research & Development is $35000.0 (2023), against an average of $40647.1.
  • Across the five-year window, Research & Development sank 91.29% in 2022 and surged 157.14% in 2025, its largest moves.
  • CV Sciences' Research & Development stood at $33000.0 in 2022, then climbed by 21.21% to $40000.0 in 2023, then sank by 82.5% to $7000.0 in 2024, then soared by 157.14% to $18000.0 in 2025, then changed by 0.0% to $18000.0 in 2026.
  • The last three Research & Development figures came in at $18000.0 (Q1 2026), $18000.0 (Q4 2025), and $24000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 CV Sciences - - 1.56 Mn 18,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 18,000.00
Dec 31, 2025 18,000.00
Sep 30, 2025 24,000.00
Jun 30, 2025 50,000.00
Mar 31, 2025 30,000.00
Dec 31, 2024 7,000.00
Sep 30, 2024 29,000.00
Jun 30, 2024 28,000.00
Mar 31, 2024 36,000.00
Dec 31, 2023 40,000.00
Sep 30, 2023 40,000.00
Jun 30, 2023 36,000.00
Mar 31, 2023 35,000.00
Dec 31, 2022 33,000.00
Sep 30, 2022 44,000.00
Jun 30, 2022 102,000.00
Mar 31, 2022 121,000.00
Dec 31, 2021 379,000.00
Sep 30, 2021 410,000.00
Jun 30, 2021 225,000.00